Skip to main content
Clinical Trials/NCT05659823
NCT05659823CompletedPhase 4

Impact of Guideline Recommendations for Post-caesarean Analgesia on Pain, Nausea and Pruritus

Conrad Arnfinn Bjørshol1 site in 1 country108 target enrollmentStarted: November 2, 2020Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
108
Locations
1
Primary Endpoint
Postoperative pain at 30 minutes

Study Overview

Brief Summary

To examine if perioperative pain/nausea/pruritus is altered when current standard analgesia for caesarian section (CS) is replaced with new guideline recommended analgesia.

Detailed Description

Control group (current analgesia, elective CS) is compared to current analgesia for emergency CS, and guideline recommended analgesia.

Current analgesia for CS:

Spinal hyperbaric bupivacaine 5 mg/ml, 9-11 mg. Spinal fentanyl 10-15 ug. Postoperative: Paracetamol 1g x 4, ibuprofen 400 mg x 4 po, oxycodone 10 mg (<70 kg) or 20 mg (>70 kg) x 2 po, additional oxycodone 2,5 mg iv/5 mg po when needed.

Guideline recommended analgesia for CS:

Spinal hyperbaric bupivacaine 5 mg/ml, 9-11 mg. Spinal fentanyl 12,5 ug. Spinal morphine 0,05 mg. After delivery of baby: Dexamethasone 8 mg iv, paracetamol 1g iv, parecoxib 40 mg iv.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Healthy parturient, term pregnancy, undergoing caesarian section

Exclusion Criteria

  • Patient refusal
  • Maternal heart or lung disease (not including mild asthma)
  • Known or suspected obstructive sleep apnoea syndrome
  • Pre-eclampsia
  • Body mass index > 40
  • Indulin-dependent diabetes mellitus
  • Contraindications to ibuprofen, dexamethasone or morphine
  • Chronic pain
  • Neurological disease
  • Drug abuse
  • Age < 18 years
  • American Society of Anesthesiologists (ASA) 3
  • Patients receiving other forms of anaesthesia (epidural or general)

Arms & Interventions

Control group

Active Comparator

Elective CS patients receiving current analgesia.

Intervention: Bupivacaine-fentanyl elective group (Drug)

Intervention group

Experimental

Elective CS patients receiving guideline recommended analgesia.

Intervention: Bupivacaine-fentanyl-morphine elective group (Drug)

Emergency group

Experimental

Emergency CS receiving current analgesia.

Intervention: Bupivacaine-fentanyl emergency group (Drug)

Outcomes

Primary Outcomes

Postoperative pain at 30 minutes

Time Frame: At postoperative care unit 30 minutes after arrival

Postoperative pain during rest and movement measured by numeric rating scale (NRS).

Postoperative pain at 60 minutes

Time Frame: At postoperative care unit 60 minutes after arrival

Postoperative pain during rest and movement measured by numeric rating scale (NRS).

Postoperative pain at maternity ward 8 hours after arrival

Time Frame: At maternity ward 8 hours after arrival

Postoperative pain during rest and movement measured by numeric rating scale (NRS).

Postoperative pain at maternity ward 12 hours after arrival

Time Frame: At maternity ward 12 hours after arrival

Postoperative pain during rest and movement measured by numeric rating scale (NRS).

Postoperative pain at maternity ward arrival

Time Frame: Immediately upon arrival at maternity ward

Postoperative pain during rest and movement measured by numeric rating scale (NRS).

Postoperative pain at maternity ward 16 hours after arrival

Time Frame: At maternity ward 16 hours after arrival

Postoperative pain during rest and movement measured by numeric rating scale (NRS).

Postoperative pain at postoperative care unit arrival

Time Frame: Immediately upon arrival at postoperative care unit

Postoperative pain during rest and movement measured by numeric rating scale (NRS).

Postoperative pain at 90 minutes

Time Frame: At postoperative care unit 90 minutes after arrival

Postoperative pain during rest and movement measured by numeric rating scale (NRS).

Postoperative pain at 120 minutes

Time Frame: At postoperative care unit 120 minutes after arrival

Postoperative pain during rest and movement measured by numeric rating scale (NRS).

Postoperative pain at maternity ward 4 hours after arrival

Time Frame: At maternity ward 4 hours after arrival

Postoperative pain during rest and movement measured by numeric rating scale (NRS).

Postoperative pain at maternity ward 20 hours after arrival

Time Frame: At maternity ward 20 hours after arrival

Postoperative pain during rest and movement measured by numeric rating scale (NRS).

Secondary Outcomes

  • Postoperative nausea and vomiting at maternity ward(During stay at maternity ward, estimated average 22 hours)
  • Postoperative pruritus at maternity ward(During stay at maternity ward, estimated average 22 hours)
  • Postoperative additional oxycodone consumption at maternity ward(During stay at maternity ward, estimated average 22 hours)
  • Postoperative pruritus at postoperative care unit(During stay at postoperative care unit, estimated average 2 hours)
  • Postoperative additional oxycodone consumption at postoperative care unit(During stay at postoperative care unit, estimated average 2 hours)
  • Postoperative nausea and vomiting at postoperative care unit(During stay at postoperative care unit, estimated average 2 hours)

Investigators

Sponsor
Conrad Arnfinn Bjørshol
Sponsor Class
Other Gov
Responsible Party
Sponsor Investigator
Principal Investigator

Conrad Arnfinn Bjørshol

Senior researcher

Helse Stavanger HF

Study Sites (1)

Loading locations...

Similar Trials